What is Cancer Screening Adherence?
Cancer screening adherence means completing recommended cancer screenings on time based on age, risk level, and clinical guidelines.
Cancer screening adherence measures whether people who are eligible for screening actually complete it. It applies to screenings such as mammography, colon cancer screening, cervical cancer screening, lung cancer screening, prostate cancer screening, and skin checks.
Why It Matters
Screening adherence is critical because cancer is often more treatable when found earlier. Data from Color’s book of business states that 48% of people are not up to date on cancer screening across five core cancers, based on external screening adherence benchmarks.
For employers and health plans, low cancer screening adherence can lead to later diagnoses, higher claims, more intensive treatment, and greater disruption for employees and families.
How cancer screening adherence works
Improving cancer screening adherence usually requires:
Eligibility identification: Determining who is due for screening based on age, risk, family history, symptoms, and prior screenings.
Education: Explaining why screening matters and what test is appropriate.
Access support: Offering at-home tests, imaging referrals, onsite events, scheduling support, and reminders.
Barrier reduction: Addressing time, transportation, cost concerns, fear, language, health literacy, and distrust.
Follow-up tracking: Making sure completed tests are reviewed and abnormal results receive clinical follow-up.
Color provides multi-channel engagement strategies, at-home tests, imaging access, and clinical follow-up designed to increase participation and completion.
Cancer Screening Adherence in the Context of Employee Benefits
A passive reminder is rarely enough. Employees may need education, trust-building, clear next steps, flexible access, and clinical support.
Benefits teams should measure screening adherence by eligible population, screening type, completion rate, follow-up rate after abnormal results, and time from abnormal result to diagnosis.
Key Takeaways
Cancer screening adherence measures whether eligible people complete recommended cancer screenings on time.
Low adherence can contribute to delayed detection, higher costs, and worse outcomes.
Color supports screening adherence through risk assessment, engagement, at-home screening, imaging access, and clinical follow-up.
Frequently Asked Questions
Q: Why do people skip cancer screenings?
A: Common reasons include confusion about eligibility, fear, lack of time, transportation barriers, cost concerns, language barriers, distrust, and difficulty scheduling appointments.
Q: How can employers improve cancer screening adherence?
A: Employers can improve adherence with targeted education, at-home testing, onsite events, convenient scheduling, reminders, incentives, and clinical support for follow-up.
Q: What is a good cancer screening adherence program?
A: A good program identifies who is due, makes screening easy, supports people through completion, and clinically manages abnormal results until next steps are complete.